|
Exosurf NeonatalDrug - Exosurf Neonatal The trade name of the product as shown on the labeling.
Dosage -
FOR SUSPENSION; INTRATRACHEAL
Active Ingredient(s) -
Cetyl Alcohol; Colfosceril Palmitate; Tyloxapol
Strength -
12MG/VIAL;108MG/VIAL;8MG/VIAL
Applicant -
GLAXOSMITHKLINE
New Drug Application (NDA) Number -
020044
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Aug 2, 1990
Reference Listed Drug (RLD) -
Yes
Type -
RX
Applicant Full Name -
Glaxosmithkline
Exosurf Neonatal
Zyrtec 5mg Tablet; Oral
Zyrtec-d 12 Hour 5mg;120mg Tablet, Extended Release; Oral Cetrotide Eq 0.25mg Base/ml Injectable; Injection Cetrotide Eq 3mg Base/ml Injectable; Injection Exosurf Neonatal 12mg/vial;108mg/vial;8mg/vial For Suspension; Intratracheal Tymtran 0.02mg/ml Injectable; Injection Zyrtec 5mg/5ml Syrup; Oral Zyrtec 10mg Tablet, Chewable; Oral Zyrtec 5mg Tablet, Chewable; Oral Zyrtec 10mg Tablet; Oral NewDrugInformation |